Israele - ebraico - Ministry of Health

unipharm trading ltd, israel - sitagliptin as hydrochloride - טבליות מצופות פילם - sitagliptin as hydrochloride 100 mg - sitagliptin

Israele - ebraico - Ministry of Health

unipharm trading ltd, israel - sitagliptin as hydrochloride - טבליות מצופות פילם - sitagliptin as hydrochloride 25 mg - sitagliptin

Israele - ebraico - Ministry of Health

unipharm trading ltd, israel - sitagliptin as hydrochloride - טבליות מצופות פילם - sitagliptin as hydrochloride 50 mg - sitagliptin

Israele - ebraico - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israele - ebraico - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 2 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolism. coumadin is indicated for the prophylaxis and/or treatment of the tromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israele - ebraico - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 2.5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israele - ebraico - Ministry of Health

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolis. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Israele - ebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 60 mg - duloxetine

Israele - ebraico - Ministry of Health

truemed ltd, israel - nitisinone - טבליה - nitisinone 10 mg - nitisinone

Israele - ebraico - Ministry of Health

truemed ltd, israel - nitisinone - טבליה - nitisinone 2 mg - nitisinone